Search clinical trials for: CD19-specific T cells

Total 498265 results

Seattle Children's Hospital

Active, not recruiting

CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma

Lymphoma | Leukemia

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Alaunos Therapeutics; Intrexon Corporation

Completed

CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies

Lymphoma | B-cell Lymphoma

United States
St. Jude Children's Research Hospital

Active, not recruiting

Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia, Refractory

United States
M.D. Anderson Cancer Center
Ziopharm Oncology

Completed

Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

Lymphoma | Leukemia

United States
M.D. Anderson Cancer Center

Withdrawn

Infusion of Allogeneic, 3rd Party CD19-specific T Cells

Lymphoma | Leukemia | Blood And Marrow Transplantation
M.D. Anderson Cancer Center

Completed

CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)

Leukemia | Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells

Lymphoma | Leukemia

United States
Second Military Medical University

Unknown

Immunotherapy Using Autologous T Cell-Engineered With CD19-specific Chimeric Antigen Receptor for the Treatment of Recurrent /Refractory B Cell Leukemia

Recurrent B-Cell Tumor | Refractory B-Cell Tumor

China
Shanghai Ming Ju Biotechnology Co., Ltd.

Not yet recruiting

CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma

Non-Hodgkin Lymphoma | Large B-cell Lymphoma

China
Adicet Therapeutics

Not yet recruiting

A Phase 1/2 Trial of ADI-270 in ccRCC

Clear Cell Renal Cell Carcinoma
Wake Forest University Health Sciences
Brookdale University Hospital Medical Center; Atrium Health Levine Cancer Institute

Not yet recruiting

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Myeloproliferative Neoplasm

United States
Henan Cancer Hospital

Recruiting

L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma

Relapsed/Refractory B-cell Lymphomas

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Anti-cancer DC Cell Vaccination to Treat Solid Tumors

Solid Tumor, Adult | DC

China
Zhejiang University

Not yet recruiting

Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Cancer

Pancreatic Cancer Non-resectable
M.D. Anderson Cancer Center

Not yet recruiting

T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.

Metastatic Soft-tissue Sarcoma

United States
University of Sydney
University of Manitoba

Not yet recruiting

TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients

Rejection; Transplant, Kidney | Rejection; Transplant, Pancreas

Australia, Canada, New Zealand
Centre Hospitalier Régional d'Orléans

Not yet recruiting

Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients. (LYMPHOVIRCT)

Chronic Kidney Diseases
The First Affiliated Hospital with Nanjing Medical...
Nanjing Legend Biotech Co.

Not yet recruiting

LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

China
Soligenix

Not yet recruiting

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL (FLASH2)

Mycosis Fungoides | Cutaneous T Cell Lymphoma | CTCL | CTCL/ Mycosis Fungoides
RenJi Hospital

Not yet recruiting

A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients

Prostate Cancer | Circulating Tumor Cell | Leukapheresis

China
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Efficacy of Methylprednisolone Pulses in Neuroendocrine Celles Hyperplasia of Infancy : An Early Phase Study (CORTICONEHI)

Neuroendocrine Cell Hyperplasia of Infancy

France
Novartis Pharmaceuticals

Not yet recruiting

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Diffuse Cutaneous Systemic Sclerosis
Janssen Research & Development, LLC

Recruiting

A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin | Relapsed B-cell NHL | Refractory B-Cell NHL

Turkey
Centre Hospitalier Universitaire de Saint Etienne
Sanofi Pasteur, a Sanofi Company

Recruiting

Analyzes of Nasal Tissue-resident Memory Immune Cells and Peripheral Memory Cells Able to Migrate to Airway Tissues (MUCOVAC) (MUCOVAC)

Healthy Volunteers

France
Xianmin Song, MD

Recruiting

Reduced Intensity Conditioning With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory Peripheral T-cell Lymphoma.

Peripheral T Cell Lymphoma

China
Isfahan University of Medical Sciences

Recruiting

Mesenchymal Stem Cells Derived Exosomes in Osteoarthritis Patients

Osteoarthritis, Knee

Iran, Islamic Republic of
Institute of Hematology & Blood Diseases Hospital...

Recruiting

A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma

B-cell Non-Hodgkin Lymphoma

China
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma (CD19-CARNK/T)

Mantle Cell Lymphoma (MCL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | Diffuse Large B Cell Lymphoma( DLBCL)
Minovia Therapeutics Ltd.

Recruiting

A Study to Evaluate the MNV-201 in Patients With Low Risk MDS

Myelodysplastic Syndromes

Israel
Seattle Children's Hospital

Not yet recruiting

REACT-01: Reversing Autoimmunity Through Cell Therapy

Systemic Lupus Erythematosus

United States
Hackensack Meridian Health
Preprogen

Recruiting

Endometrial Cell Collection With the PadKit

Neoplasms

United States
Emory University
The Marcus Foundation

Not yet recruiting

A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)

Dilated Cardiomyopathy

United States
Zhejiang Provincial People's Hospital
Zhejiang University; Hangzhou RonGu Biotechnology Limited Company

Not yet recruiting

Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer

Gastric Cancer | Pancreas Adenocarcinoma

China
Changhai Hospital
Rui Therapeutics

Not yet recruiting

An Exploratory Clinical Study of CD19 CAR NK Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Autoimmune Diseases
Tr1X, Inc.

Recruiting

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Myelodysplastic Syndromes | Hematologic Malignancy | Hematopoietic Stem Cell Transplant | Acute Myeloid Leukemia in Remission | GVHD, Chronic | GVHD,Acute | GvHD | Acute Lymphoblastic Leukemia, Adult B-Cell | Cancer Remission | Acute Lymphoblastic Leukemia, Adult T-Cell | Chronic Myelomonocytic Leukemia,...

United States
Zhejiang University
Carbiogene Therapeutics Co. Ltd.

Not yet recruiting

Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma

China
NYU Langone Health

Not yet recruiting

Packed Red Blood Cell Transfusion During Cardiac Arrest

Cardiac Arrest

United States
TC Biopharm

Not yet recruiting

ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)/AML (ACHIEVE2)

Acute Myeloid Leukemia | Myelodysplastic Syndromes
Chi Kong Li
Hong Kong Children's Hospital

Recruiting

Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies

Leukemia, Lymphocytic | Lymphoma, Nonhodgkin

China
Koo Foundation Sun Yat-Sen Cancer Center

Recruiting

Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma (PentixaFor)

Indolent B-Cell Non-Hodgkin Lymphoma

Taiwan
Weill Medical College of Cornell University
Angiocrine Bioscience

Not yet recruiting

E-CEL UVEC Treatment for Anal Fissures

Chronic Anal Fissure (Medical Refractory)

United States
IRCCS San Raffaele Roma

Recruiting

NK-ORB Expression of Mu Receptor on Lymphocytes in Rehabilitation (NK-ORB)

Fibromyalgia

Italy
Abramson Cancer Center at Penn Medicine
Genmab

Not yet recruiting

Epcoritamab-CAR T Cells for Large B-cell Lymphomas

Lymphoma, Non-Hodgkin | High-grade B-cell Lymphoma | Refractory Diffuse Large B-cell Lymphoma | Relapsed Diffuse Large B Cell Lymphoma | Transformed Indolent Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma

United States
University of California, Irvine
Eurofins Viracor

Not yet recruiting

Prospect Eval of Efficacy of CMV-TCIP Direct Letermovir Prophylax After Allogen Hemato Cell Transpla

CMV | Allogeneic Stem Cell Transplantation

United States
Bruce Cree
Kyverna Therapeutics

Recruiting

A Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants With Treatment Refractory Progressive Multiple Sclerosis

Progressive Multiple Sclerosis

United States
Peking University People's Hospital
Beijing 302 Hospital; The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Using Multiparametric Flow Cytometry to Detect Peripheral Blood and Bone Marrow Leukaemia Stem Cells for Relapse Prediction in P-AML

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia
Regeneron Pharmaceuticals

Recruiting

A First In Human (FIH) Study to Learn if Different Doses of ALN-ANG3 Are Safe and Well Tolerated in Healthy Adults

Healthy Volunteers

New Zealand
Swiss Group for Clinical Cancer Research

Not yet recruiting

NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline

Breast Cancer

Switzerland
Zumutor Biologics Inc.

Recruiting

Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

Colorectal Cancer | Esophageal Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreas Adenocarcinoma | Diffuse Large B Cell Lymphoma | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Biliary Tract Cancer | High Grade Ovarian Serous Adenocarcinoma

United States
Anhui Medical University

Not yet recruiting

Establishment of Reproductive Cohort and Prediction Model of Genetic Counseling for Mitochondrial Genetic Diseases

Mitochondrial Diseases

Search clinical trials for: CD19-specific T cells

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations